未登录

Y

Yu-Jeong Choi

exollence co., ltd.

H指数:15

被引数:618

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A single extracellular vesicle-based platform supporting both RBD protein and mRNA vaccination against SARS-CoV-2

一种基于外泌体的单平台，支持针对SARS-CoV-2的RBD蛋白及mRNA疫苗接种

Journal of Controlled Release

IF11.5

2025-12-060

PRE

Natural Product-Derived Drugs: Structural Insights into Their Biological Mechanisms

天然产物衍生药物：对其生物机制的结构见解

Biomolecules 2025, Vol. 15, Page 1303

IF0

2025-09-100

OAAI

The combination of SH003 and DTX induces cytotoxic cell infiltration in anti-PD1 resistant lung cancer

SH003和DTX的组合在抗PD1耐药性肺癌中诱导细胞毒性细胞浸润

CANCER IMMUNOLOGY IMMUNOTHERAPY

IF5.1

2025-05-100

OA

Quercetin: Molecular Insights into Its Biological Roles

槲皮素：关于其生物学作用的分子洞察

IF4.8

2025-02-200

OA

Scalable production of siRNA-encapsulated extracellular vesicles for the inhibition of KRAS-mutant cancer using acoustic shock waves

JOURNAL OF EXTRACELLULAR VESICLES

IF14.5

2024-09-261

OA

p53 activation enhances the sensitivity of non-small cell lung cancer to the combination of SH003 and docetaxel by inhibiting de novo pyrimidine synthesis

CANCER CELL INTERNATIONAL

IF6

2024-05-042

OAAI

Targeting Heme Oxygenase 2 (HO2) with TiNIR, a Theragnostic Approach for Managing Metastatic Non-Small Cell Lung Cancer

BIOMATERIALS RESEARCH

IF9.6

2024-04-252

OAAI

Next-generation RNAi therapeutics: siRNA-loaded exosomes targeting KRAS G12C in non-small cell lung cancer (NSCLC)

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer

BMC COMPLEMENTARY MEDICINE AND THERAPIES

IF3.4

2024-02-010

OAAI

Paeonia lactiflora Pallas extract alleviates Antibiotics and DNCB-induced atopic dermatitis symptoms by suppressing inflammation and changing the gut microbiota composition in mice (vol 154, 113574, 2022)

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2023-09-010

OAAI

Synergistic effect of SH003 and Docetaxel by targeting a metabolic pathway in non-small cell lung cancer cells

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Loss of GPR54 inhibits tumor growth by suppressing AKT/DDC signaling pathway in KRAS-mutant non-small cell lung cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Metabolomic Analysis of Exosomes Derived from Lung Cancer Cell Line H460 Treated with SH003 and Docetaxel

IF3.7

2022-10-285

OAAI

Paeonia lactiflora Pallas extract alleviates antibiotics and DNCB-induced atopic dermatitis symptoms by suppressing inflammation and changing the gut microbiota composition in mice

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-10-0110

OAAI

Reduced HIF-1α Stability Induced by 6-Gingerol Inhibits Lung Cancer Growth through the Induction of Cell Death

IF4.6

2022-03-246

OAAI

Platycodin D inhibits autophagy and increases glioblastoma cell death via LDLR upregulation

MOLECULAR ONCOLOGY

IF4.5

2021-05-0239

OAAI

Platycodin D enhances LDLR expression and LDL uptake via down-regulation of IDOL mRNA in hepatic cells

SCIENTIFIC REPORTS

IF3.9

2020-11-1630

OAAI

p53 causes butein-mediated apoptosis of chronic myeloid leukemia cells

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling

CANCER RESEARCH

IF16.6

2019-07-011

PRE

A biomarker development for NSCLC patients based on pattern identification of traditional Korean medicine: A pilot study

CANCER RESEARCH

IF16.6

2019-07-010

PRE